Dr. Hegerova is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000Fax+1 206-215-1655
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 2014 - 2017
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2011 - 2014
- University of Washington School of MedicineClass of 2011
Certifications & Licensure
- WA State Medical License 2017 - 2025
- MN State Medical License 2012 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA Start of enrollment: 2019 Apr 24
- Phase 1/2 Study of REGN5458 in Adult Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2019 Jan 23
Roles: Contact
Publications & Presentations
PubMed
- Successful treatment of acquired von Willebrand syndrome secondary to low-grade CLL with rituximab and venetoclax.Aaron Boothby, Livia Hegerova, Shelley N Fletcher, Mazyar Shadman, Jill M Johnsen
Leukemia & Lymphoma. 2024-12-01 - Neurosurgical bleeding in platelet storage pool disorder: a case report.Clifford Pierre, Kirsten W Alcorn, Dong Chen, Joanna Fesler, Daniel Landis
Platelets. 2024-12-01 - 10 citationsJAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma.Jaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, Kristi L Marquardt, Reza Beheshti Zavareh
Science. 2024-06-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: